BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
39 hedge funds and large institutions have $9.38M invested in BRAINSTORM CELL THERAPUTC in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.21% more ownership
Funds ownership: 0.59% → 0.8% (+0.21%)
Holders
39
Holding in Top 10
1
Calls
$212K
Puts
–
Top Buyers
| 1 | +$3.54M | |
| 2 | +$507K | |
| 3 | +$103K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$76.2K |
| 5 |
CPP
Crow Point Partners
Boston,
Massachusetts
|
+$72.5K |
Top Sellers
| 1 | -$1.26M | |
| 2 | -$94K | |
| 3 | -$15K | |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
-$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5K |